JAMA

Medications for Obesity – A Review

Importance  Obesity affects approximately 19% of women and 14% of men worldwide and is associated with increased morbidity. Antiobesity medications (AOMs) modify biological processes that affect appetite and significantly improve outcomes, such as type 2 diabetes, hypertension, and dyslipidemia. Observations  AOMs should…

Management of Patients With Chronic Coronary Disease

This JAMA Clinical Guidelines Synopsis summarizes the 2023 American Heart Association (AHA)/American College of Cardiology (ACC) guideline on management of patients with chronic coronary disease.

Heat-Related Illness in Athletes

This JAMA Insights discusses heat-related illness in athletes, including risk factors, prevention, symptoms, and management.

Anterior Cruciate Ligament Injuries in Female Athletes

This JAMA Insights discusses anterior cruciate ligament (ACL) injuries in female athletes, including modifiable and nonmodifiable sex-based risk factors and the implementation of ACL injury prevention programs.

Obesity in Adolescents – A Review

Importance  Obesity affects approximately 21% of US adolescents and is associated with insulin resistance, hypertension, dyslipidemia, sleep disorders, depression, and musculoskeletal problems. Obesity during adolescence has also been associated with an increased risk of mortality from cardiovascular disease and type 2…

Vaping in Youth

This JAMA Insights reviews the health effects of vaping among youth in the US and current recommendations for screening and treatment.